178 related articles for article (PubMed ID: 28306358)
1. The genetics of gastroesophageal adenocarcinoma and the use of circulating cell free DNA for disease detection and monitoring.
Openshaw MR; Richards CJ; Guttery DS; Shaw JA; Thomas AL
Expert Rev Mol Diagn; 2017 May; 17(5):459-470. PubMed ID: 28306358
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma.
Kato S; Okamura R; Baumgartner JM; Patel H; Leichman L; Kelly K; Sicklick JK; Fanta PT; Lippman SM; Kurzrock R
Clin Cancer Res; 2018 Dec; 24(24):6248-6256. PubMed ID: 30348637
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma.
Openshaw MR; Suwaidan AA; Ottolini B; Fernandez-Garcia D; Richards CJ; Page K; Guttery DS; Thomas AL; Shaw JA
Br J Cancer; 2020 Oct; 123(8):1271-1279. PubMed ID: 32719550
[TBL] [Abstract][Full Text] [Related]
4. The genomic landscape of oesophagogastric junctional adenocarcinoma.
Chong IY; Cunningham D; Barber LJ; Campbell J; Chen L; Kozarewa I; Fenwick K; Assiotis I; Guettler S; Garcia-Murillas I; Awan S; Lambros M; Starling N; Wotherspoon A; Stamp G; Gonzalez-de-Castro D; Benson M; Chau I; Hulkki S; Nohadani M; Eltahir Z; Lemnrau A; Orr N; Rao S; Lord CJ; Ashworth A
J Pathol; 2013 Nov; 231(3):301-10. PubMed ID: 24308032
[TBL] [Abstract][Full Text] [Related]
5. ctDNA analysis in the personalized clinical management of gastroesophageal adenocarcinoma: turning hope into reality.
Salati M; Venetis K; Fassan M; Malapelle U; Pagni F; Sajjadi E; Fusco N; Ghidini M
Future Oncol; 2021 Nov; 17(33):4607-4618. PubMed ID: 34406032
[TBL] [Abstract][Full Text] [Related]
6. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
[TBL] [Abstract][Full Text] [Related]
7. Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma.
Maron SB; Chase LM; Lomnicki S; Kochanny S; Moore KL; Joshi SS; Landron S; Johnson J; Kiedrowski LA; Nagy RJ; Lanman RB; Kim ST; Lee J; Catenacci DVT
Clin Cancer Res; 2019 Dec; 25(23):7098-7112. PubMed ID: 31427281
[TBL] [Abstract][Full Text] [Related]
8. The role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring.
Openshaw MR; Page K; Fernandez-Garcia D; Guttery D; Shaw JA
Expert Rev Mol Diagn; 2016 Jul; 16(7):751-5. PubMed ID: 27144417
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific genetic aberrations in cell-free DNA of gastroesophageal cancer patients.
Koldby KM; Mortensen MB; Detlefsen S; Pfeiffer P; Thomassen M; Kruse TA
J Gastroenterol; 2019 Feb; 54(2):108-121. PubMed ID: 30242476
[TBL] [Abstract][Full Text] [Related]
10. Detection of Circulating Tumor DNA in Plasma: A Potential Biomarker for Esophageal Adenocarcinoma.
Egyud M; Tejani M; Pennathur A; Luketich J; Sridhar P; Yamada E; Ståhlberg A; Filges S; Krzyzanowski P; Jackson J; Kalatskaya I; Jiao W; Nielsen G; Zhou Z; Litle V; Stein L; Godfrey T
Ann Thorac Surg; 2019 Aug; 108(2):343-349. PubMed ID: 31059681
[TBL] [Abstract][Full Text] [Related]
11. The Molecular Biologic Basis of Esophageal and Gastric Cancers.
Pennathur A; Godfrey TE; Luketich JD
Surg Clin North Am; 2019 Jun; 99(3):403-418. PubMed ID: 31047032
[TBL] [Abstract][Full Text] [Related]
12.
Klempner SJ; Madison R; Pujara V; Ross JS; Miller VA; Ali SM; Schrock AB; Kim ST; Maron SB; Dayyani F; Catenacci DVT; Lee J; Chao J
Oncologist; 2019 Nov; 24(11):1462-1468. PubMed ID: 31249137
[TBL] [Abstract][Full Text] [Related]
13. Chromosomal imbalances in gastric and esophageal adenocarcinoma: specific comparative genomic hybridization-detected abnormalities segregate with junctional adenocarcinomas.
Stocks SC; Pratt N; Sales M; Johnston DA; Thompson AM; Carey FA; Kernohan NM
Genes Chromosomes Cancer; 2001 Sep; 32(1):50-8. PubMed ID: 11477661
[TBL] [Abstract][Full Text] [Related]
14. Cell-free tumour DNA analysis detects copy number alterations in gastro-oesophageal cancer patients.
Wallander K; Eisfeldt J; Lindblad M; Nilsson D; Billiau K; Foroughi H; Nordenskjöld M; Liedén A; Tham E
PLoS One; 2021; 16(2):e0245488. PubMed ID: 33539436
[TBL] [Abstract][Full Text] [Related]
15. Gastroesophageal cancer: Navigating the immune and genetic terrain to improve clinical outcomes.
Jones JO; Smyth EC
Cancer Treat Rev; 2020 Mar; 84():101950. PubMed ID: 31918022
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus.
Li X; Paulson TG; Galipeau PC; Sanchez CA; Liu K; Kuhner MK; Maley CC; Self SG; Vaughan TL; Reid BJ; Blount PL
Cancer Prev Res (Phila); 2015 Sep; 8(9):845-56. PubMed ID: 26130253
[TBL] [Abstract][Full Text] [Related]
17. Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer.
Azad TD; Chaudhuri AA; Fang P; Qiao Y; Esfahani MS; Chabon JJ; Hamilton EG; Yang YD; Lovejoy A; Newman AM; Kurtz DM; Jin M; Schroers-Martin J; Stehr H; Liu CL; Hui AB; Patel V; Maru D; Lin SH; Alizadeh AA; Diehn M
Gastroenterology; 2020 Feb; 158(3):494-505.e6. PubMed ID: 31711920
[TBL] [Abstract][Full Text] [Related]
18. Molecular Diagnostics in Esophageal and Gastric Neoplasms: 2018 Update.
Zulfiqar M; Bluth MH; Bhalla A
Clin Lab Med; 2018 Jun; 38(2):357-365. PubMed ID: 29776635
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic approaches to gastroesophageal junction adenocarcinomas.
Blom RL; Bogush T; Brücher BL; Chang AC; Davydov M; Dudko E; Leong T; Polotsky B; Swanson PE; van Rossum PS; Ruurda JP; Sagaert X; Tjulandin S; Schraepen MC; Sosef MN; van Hillegersberg R
Ann N Y Acad Sci; 2014 Sep; 1325():197-210. PubMed ID: 25266026
[TBL] [Abstract][Full Text] [Related]
20. Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia.
Gleeson CM; Sloan JM; McManus DT; Maxwell P; Arthur K; McGuigan JA; Ritchie AJ; Russell SE
Br J Cancer; 1998; 77(2):277-86. PubMed ID: 9460999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
